| Literature DB >> 29343554 |
Damian L Turner1,2, Monica Goldklang3, Filip Cvetkovski1,4, Daniel Paik1, Jordis Trischler3, Josselyn Barahona5, Minwei Cao5, Ronak Dave5, Nicole Tanna5, Jeanine M D'Armiento3,6, Donna L Farber7,4,8.
Abstract
Asthma is a chronic inflammatory disease mediated by allergen-specific CD4 T cells that promote lung inflammation through recruitment of cellular effectors into the lung. A subset of lung T cells can persist as tissue-resident memory T cells (TRMs) following infection and allergen induction, although the generation and role of TRM in asthma persistence and pathogenesis remain unclear. In this study, we used a mouse model of chronic exposure to intranasal house dust mite (HDM) extract to dissect how lung TRMs are generated and function in the persistence and pathogenesis of allergic airway disease. We demonstrate that both CD4+ and CD8+ T cells infiltrate into the lung tissue during acute HDM exposure; however, only CD4+ TRMs, and not CD8+ TRMs, persist long term following cessation of HDM administration. Lung CD4+ TRMs are localized around airways and are rapidly reactivated upon allergen re-exposure accompanied by the rapid induction of airway hyperresponsiveness independent of circulating T cells. Lung CD4+ TRM activation to HDM challenge is also accompanied by increased recruitment and activation of dendritic cells in the lungs. Our results indicate that lung CD4+ TRMs can perpetuate allergen-specific sensitization and direct early inflammatory signals that promote rapid lung pathology, suggesting that targeting lung CD4+ TRMs could have therapeutic benefit in alleviating recurrent asthma episodes.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29343554 PMCID: PMC5821590 DOI: 10.4049/jimmunol.1700257
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422